SSGJ-706 is named as an intervention in 2 current clinical trials in our China register. 1 is recruiting patients now. All registered phases are Phase 2. The lead sponsor is Shenyang Sunshine Pharmaceutical Co., LTD. The most-studied condition is Gastric/Gastroesophageal Junction Adenocarcinoma.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer๏ผNSCLC๏ผ Patients
NCT07171606 · ClinicalTrials.gov ↗ · First-line Advanced NSCLC Patients
|
Phase 2 | Recruiting | Shenyang Sunshine Pharmaceutical Co., LTD | China |
|
A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers
NCT07233850 · ClinicalTrials.gov ↗ · Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
|
Phase 2 | Not yet open | Shenyang Sunshine Pharmaceutical Co., LTD | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Shenyang Sunshine Pharmaceutical Co., LTD | 2 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our China register name SSGJ-706 as a drug or biological intervention, as of the registry sync on 1 October 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
The lead sponsor is Shenyang Sunshine Pharmaceutical Co., LTD. The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how SSGJ-706 works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records โ it is not written from memory, and nothing here describes how SSGJ-706 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists SSGJ-706 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 1 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.